Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients

HIV Medicine

Volumn 8, Issue 3, 2007, Pages 181-185

  Ho, C F ^a   Lee, S S ^b   Wong, K H ^a   Cheng, L S ^a   Lam, M Y ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CD4 threshold; ChineseHIV infected patients; HAART

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINESE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORMAL VALUE; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; RISK FACTOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; VIRAL LOAD;

EID: 34250339669     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2007.00450.x     Document Type: Article

References (9)

1. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
2. Wong KH, Chan KCW, Lee SS. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 39: 853-860.
3. Bartlett JG, Gallan JE. Medical Management of HIV Infection. Baltimore, Maryland, Johns Hopkins Medicine Health Publishing Business Group, 2004.
4. Gazzard B; BHIVA Writing Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with artiretroviral therapy (2005). HIV Med 2005; 6 (Suppl. 2): 1-61.
5. The European AIDS Clinical Society (EACS) Euroguidelines Group. European guidelines for the clinical management and treatment of HIV-infected adults in Europe. AIDS 2003; 17 (Suppl. 2): S3-S26.
6. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. http://aidsinfo.nih.gov/Guidelines/ GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID= 7&ClassID=1 2003.
7. Kam KM, Leung WL, Kwok MY et al. Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults. Clin Diagn Lab Immunol 1996; 3: 326-330.
8. Wong KH, Lee SS, Kam KM. Decline of CD4 level and its correlation with clinical events in Chinese HIV-infected patients. J Infect Dis Antimicrob Agents 1998; 15: 99-103.
9. Centres for Disease Control and Prevention of the United States. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbility and Mortality weekly Report (MMWR Recomm Rep) 1992; 41: 1-19.